Free Trial

Mackenzie Financial Corp Increases Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background

Mackenzie Financial Corp grew its holdings in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 38.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,807 shares of the company's stock after purchasing an additional 2,168 shares during the period. Mackenzie Financial Corp's holdings in Molina Healthcare were worth $2,272,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Blue Trust Inc. increased its stake in Molina Healthcare by 35.5% in the 4th quarter. Blue Trust Inc. now owns 649 shares of the company's stock valued at $189,000 after buying an additional 170 shares during the last quarter. R Squared Ltd acquired a new stake in shares of Molina Healthcare in the fourth quarter valued at about $114,000. Forsta AP Fonden raised its holdings in Molina Healthcare by 3.4% during the fourth quarter. Forsta AP Fonden now owns 12,300 shares of the company's stock worth $3,580,000 after acquiring an additional 400 shares in the last quarter. Caprock Group LLC boosted its position in Molina Healthcare by 18.1% during the fourth quarter. Caprock Group LLC now owns 1,724 shares of the company's stock valued at $502,000 after purchasing an additional 264 shares during the last quarter. Finally, Custom Index Systems LLC boosted its position in Molina Healthcare by 24.8% during the fourth quarter. Custom Index Systems LLC now owns 1,401 shares of the company's stock valued at $408,000 after purchasing an additional 278 shares during the last quarter. Institutional investors own 98.50% of the company's stock.

Insiders Place Their Bets

In related news, Director Richard M. Schapiro sold 669 shares of the business's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the transaction, the director now directly owns 11,244 shares in the company, valued at approximately $3,603,702. The trade was a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the sale, the chief executive officer now owns 257,715 shares of the company's stock, valued at approximately $82,484,262.90. This trade represents a 25.35% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.10% of the company's stock.

Analyst Ratings Changes

Several research firms have weighed in on MOH. Stephens reaffirmed an "equal weight" rating and set a $345.00 price target on shares of Molina Healthcare in a research report on Thursday, February 6th. Wells Fargo & Company raised shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their price target for the stock from $295.00 to $372.00 in a research report on Wednesday, March 5th. Baird R W downgraded shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Mizuho upped their target price on shares of Molina Healthcare from $376.00 to $400.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Finally, UBS Group reduced their price target on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a report on Friday, February 7th. Nine research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, Molina Healthcare presently has a consensus rating of "Hold" and a consensus target price of $364.54.

Read Our Latest Analysis on MOH

Molina Healthcare Trading Down 0.4%

Shares of MOH stock traded down $1.11 during trading hours on Wednesday, hitting $292.48. 560,537 shares of the company were exchanged, compared to its average volume of 685,153. The company has a 50 day simple moving average of $321.88 and a two-hundred day simple moving average of $307.09. The firm has a market cap of $15.85 billion, a P/E ratio of 14.32, a P/E/G ratio of 1.06 and a beta of 0.63. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $365.23.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, beating the consensus estimate of $5.96 by $0.12. The firm had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The business's quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $5.73 earnings per share. Equities analysts anticipate that Molina Healthcare, Inc. will post 24.4 EPS for the current year.

Molina Healthcare Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

See Also

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines